Esquizofrenia y su asociación con enfermedades médicas crónicas

The life expectancy of patients with schizophrenia (SCH) is 11 to 20 years less than the general population. There is an association between SCH and various diseases and chronic conditions, highlighting the cardio-metabolic diseases. This association has been attributed to the use of antipsychotics,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Orellana,Gricel, Rodríguez,Matías, González,Nicolás, Durán,Eduardo
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2017
Materias:	Antipsychotic Agents Metabolic Syndrome X Schizophrenia
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000801047
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872017000801047
record_format	dspace
spelling	oai:scielo:S0034-988720170008010472017-11-27Esquizofrenia y su asociación con enfermedades médicas crónicasOrellana,GricelRodríguez,MatíasGonzález,NicolásDurán,Eduardo Antipsychotic Agents Metabolic Syndrome X Schizophrenia The life expectancy of patients with schizophrenia (SCH) is 11 to 20 years less than the general population. There is an association between SCH and various diseases and chronic conditions, highlighting the cardio-metabolic diseases. This association has been attributed to the use of antipsychotics, however, evidence has also shown intrinsic susceptibility of schizophrenic patients the development of chronic conditions. This review aims to update knowledge about chronic conditions such as cardiometabolic risk and sleep, bone and kidney disorders related to SCH. These patients have a high prevalence of risk behaviors, including smoking and poor diet. They have a worse metabolic profile than the general population and a greater likelihood of developing metabolic syndrome, diabetes and cardiovascular disease. SCH has also been associated with other chronic diseases such as osteoporosis and chronic kidney disease. The high prevalence of these comorbidities in schizophrenic population is not explained solely by the antipsychotic treatment, therefore intrinsic mechanisms associated to SCH are postulated to be associated with these conditions. This new information requires a change in the multidisciplinary medical approach for the study and management of schizophrenic patients.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.145 n.8 20172017-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000801047es10.4067/s0034-98872017000801047
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Antipsychotic Agents Metabolic Syndrome X Schizophrenia
spellingShingle	Antipsychotic Agents Metabolic Syndrome X Schizophrenia Orellana,Gricel Rodríguez,Matías González,Nicolás Durán,Eduardo Esquizofrenia y su asociación con enfermedades médicas crónicas
description	The life expectancy of patients with schizophrenia (SCH) is 11 to 20 years less than the general population. There is an association between SCH and various diseases and chronic conditions, highlighting the cardio-metabolic diseases. This association has been attributed to the use of antipsychotics, however, evidence has also shown intrinsic susceptibility of schizophrenic patients the development of chronic conditions. This review aims to update knowledge about chronic conditions such as cardiometabolic risk and sleep, bone and kidney disorders related to SCH. These patients have a high prevalence of risk behaviors, including smoking and poor diet. They have a worse metabolic profile than the general population and a greater likelihood of developing metabolic syndrome, diabetes and cardiovascular disease. SCH has also been associated with other chronic diseases such as osteoporosis and chronic kidney disease. The high prevalence of these comorbidities in schizophrenic population is not explained solely by the antipsychotic treatment, therefore intrinsic mechanisms associated to SCH are postulated to be associated with these conditions. This new information requires a change in the multidisciplinary medical approach for the study and management of schizophrenic patients.
author	Orellana,Gricel Rodríguez,Matías González,Nicolás Durán,Eduardo
author_facet	Orellana,Gricel Rodríguez,Matías González,Nicolás Durán,Eduardo
author_sort	Orellana,Gricel
title	Esquizofrenia y su asociación con enfermedades médicas crónicas
title_short	Esquizofrenia y su asociación con enfermedades médicas crónicas
title_full	Esquizofrenia y su asociación con enfermedades médicas crónicas
title_fullStr	Esquizofrenia y su asociación con enfermedades médicas crónicas
title_full_unstemmed	Esquizofrenia y su asociación con enfermedades médicas crónicas
title_sort	esquizofrenia y su asociación con enfermedades médicas crónicas
publisher	Sociedad Médica de Santiago
publishDate	2017
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000801047
work_keys_str_mv	AT orellanagricel esquizofreniaysuasociacionconenfermedadesmedicascronicas AT rodriguezmatias esquizofreniaysuasociacionconenfermedadesmedicascronicas AT gonzaleznicolas esquizofreniaysuasociacionconenfermedadesmedicascronicas AT duraneduardo esquizofreniaysuasociacionconenfermedadesmedicascronicas
_version_	1718436960943472640

Esquizofrenia y su asociación con enfermedades médicas crónicas

Ejemplares similares